Klow 80 mg

Dragon Pharma Klow

Recovery is a limiting factor for long-term progress in both bodybuilding and athletic training. Joint stress, connective tissue wear, gut irritation, and systemic inflammation can accumulate quickly under heavy workloads. Dragon Pharma Klow 80 mg is a pre-formulated multi-peptide blend created for research into comprehensive recovery pathways. By combining four well-studied peptides into a single vial, Klow simplifies protocols aimed at tissue repair, inflammation control, and structural support. When you Buy Klow by Dragon Pharma, you're choosing a consolidated recovery-focused research compound produced to Legit Dragon Pharma standards.

Klow Composition

Each 2 mL vial contains 80 mg of lyophilized peptides, combining four complementary compounds:

• KPV (10 mg): A tripeptide derived from α-MSH, commonly studied for its role in modulating inflammatory signaling, particularly within the gastrointestinal tract.
• BPC-157 (10 mg): A gastric-derived peptide researched for its role in supporting tissue repair in muscles, tendons, ligaments, and the gut lining.
• TB-500 (10 mg): A synthetic version of Thymosin Beta-4, studied for its effects on cell migration, angiogenesis, and tissue remodeling.
• GHK-Cu (50 mg): A naturally occurring copper peptide researched for collagen synthesis, connective tissue support, antioxidant activity, and regenerative signaling.

Bodybuilding & Recovery Research Benefits

Klow is designed to support multiple recovery pathways simultaneously. BPC-157 and TB-500 are commonly researched together for soft-tissue repair and structural resilience. GHK-Cu supports connective tissue integrity by influencing collagen and extracellular matrix formation, which is particularly relevant for joint and tendon stress under load. KPV contributes anti-inflammatory support, especially in the gut, which can indirectly impact nutrient absorption and overall recovery capacity during intense training phases.

Therapeutic Research Background

Each peptide included in Klow has an established research history. BPC-157 is widely studied for gastrointestinal and musculoskeletal protection. TB-500 has been investigated in tissue repair and angiogenesis models. GHK-Cu is recognized for its regenerative and wound-healing properties across skin and connective tissues. KPV is explored for its ability to help regulate inflammatory responses and oxidative stress, particularly in intestinal research models.

Dosage (Men)

Because Klow is a combined peptide blend, dosing reflects total peptide content rather than individual compounds. Research protocols often reference subcutaneous administration of approximately 200–500 mcg of the total blend once or twice daily, or every other day due to TB-500's longer tissue activity. Typical research cycles run 4–6 weeks followed by a washout period for assessment.

Dosage (Women)

Female research models generally use slightly lower total amounts, commonly in the range of 150–300 mcg per administration. Frequency and duration depend on the study design, with conservative starting protocols recommended.

Active Life

The activity profile varies by peptide. KPV and BPC-157 have relatively short activity windows, while TB-500 remains active in tissues for several days. GHK-Cu's effects on collagen synthesis and tissue remodeling are cumulative over time, which is why structured multi-week research cycles are common.

Klow Side Effects

The peptides included in Klow are generally well-tolerated in research settings. Occasional observations include minor injection-site irritation or transient warmth, particularly due to GHK-Cu. Overall adverse effects are uncommon when conservative protocols are followed.

Klow Contraindications & Precautions

Due to TB-500's involvement in angiogenesis pathways, Klow should be avoided in research models involving active malignancies. Individuals with known sensitivity to peptide compounds should avoid exposure. This product is supplied for laboratory research only and is not intended for human consumption. Pregnant or nursing individuals should not handle this compound.

Overdosage

Excessive dosing may increase the likelihood of mild effects such as injection-site discomfort, dizziness, or fatigue. No specific antidote exists; supportive monitoring and discontinuation are recommended if symptoms occur.

Klow Stack & Cycle Research

Klow is often used as a standalone recovery blend, but it may also be incorporated into broader research protocols. Bacteriostatic Water is required for reconstitution. Researchers comparing peptide ratios may evaluate GLOW as an alternative blend. For immune-focused recovery research, stacking with Thymosin Alpha-1 is common. Typical cycles last 4–6 weeks followed by an off period.

Package Presentation

Dragon Pharma Klow 80 mg is supplied in a sterile, sealed 2 mL clear glass vial containing a white to off-white lyophilized powder. Each vial is labeled with batch information and expiration date for traceability and quality assurance.

Storage

Store unopened vials in a cool, dry location away from light. Refrigeration (2–8°C / 36–46°F) is recommended for long-term storage. After reconstitution, store refrigerated and use within 28 days.

Klow Referrers

Scientific literature supports the regenerative and connective tissue-focused research use of several Klow components. GHK-Cu in particular has been extensively studied for its role in collagen synthesis, immune cell attraction, and tissue remodeling. Read more about GHK-Cu research on PubMed.